1. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy
    Jiarong Lv et al, 2020, Journal of Diabetes Research CrossRef
  2. Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy
    Shanshan Ding et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  3. FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation
    Xiaowei Wang et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  4. Cytoprotective Effect of Liposomal Puerarin on High Glucose-Induced Injury in Rat Mesangial Cells
    Lassina Barro et al, 2021, Antioxidants CrossRef
  5. The Effect of Terpenoid Natural Chinese Medicine Molecular Compound on Lung Cancer Treatment
    Heng Sun et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  6. Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy
    Ying-Ying Li et al, 2022, Front. Pharmacol. CrossRef
  7. Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
    Yi Zhu et al, 2022, Front. Pharmacol. CrossRef
  8. Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney
    Run Li et al, 2023, Front. Pharmacol. CrossRef
  9. Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K / AKT‐ERK ‐dependent Nrf2/ ARE signaling pathway in glomerular mesangial cells
    Xue Su et al, 2023, Phytotherapy Research CrossRef
  10. Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action
    Xiaoqing Wan et al, 2023, Front. Endocrinol. CrossRef
  11. Underlying mechanisms and molecular targets of genistein in the management of type 2 diabetes mellitus and related complications
    Tao Jiang et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
  12. Preclinical Investigations on Anti-fibrotic Potential of Long-Term Oral Therapy of Sodium Astragalosidate in Animal Models of Cardiac and Renal Fibrosis
    Xiao-Yi Chen et al, 2024, ACS Pharmacol. Transl. Sci. CrossRef
  13. To Develop Biomarkers for Diabetic Nephropathy Based on Genes Related to Fibrosis and Propionate Metabolism and Their Functional Validation
    Sha Li et al, 2024, Journal of Diabetes Research CrossRef
  14. Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism
    Hui-zhong Xue et al, 2024, Journal of Diabetes Research CrossRef